Real-time fluorescence quantitative PCR was employed to examine the expression of 20 clinical samples of lung adenocarcinoma, confirming once more that compared with the normal tissue group, the expression of MRPL13 in the LUAD group was higher (Figure 12A). This evidence concerns the gene MRPL13 and lung adenocarcinoma.